Furthermore, some CaSR variants have been identified incidentally in patients with FHH, but subsequently shown to have no pathogenic effect, or shown to be functionally activating when later identified in hypocalcemic individuals [6]. Here, CASR is linked to familial hypocalciuric hypercalcemia.